In-depth coverage of global biotech stocks & healthcare markets

Trial Stopped

  • What Is a Clinical Hold? When the FDA Stops a Trial and What Happens Next

    What Is a Clinical Hold? When the FDA Stops a Trial and What Happens Next

    Few announcements strike more fear into biotech investors than a clinical hold. When the FDA issues a clinical hold on a company’s Investigational New Drug application, it means the agency has identified concerns serious enough to stop human testing — either entirely or in part. Stocks frequently fall 30% to 60% or more on clinical…

    read more